Shell Asset Management’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
HA
CII
Shell Asset Management's ONC Position: Q2 2023 in Review
Shell Asset Management sold out of BeOne Medicines Ltd (ONC) in Q2 2023, closing a stake of 4,658 shares — an estimated $1M sold.
Shell Asset Management first reported a position in ONC in Q4 2018 and held it in 18 quarters. The position peaked at $8.57M in Q1 2021. 208 funds tracked by Wall St. Rank hold ONC as of Q2 2023.
- Shell Asset Management reported no remaining BeOne Medicines Ltd position as of Q2 2023 after selling out during the quarter.
- Shell Asset Management sold 4,658 BeOne Medicines Ltd shares in Q2 2023, an estimated $1M.
- Shell Asset Management first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 18 quarters.
- Shell Asset Management's BeOne Medicines Ltd position peaked at $8.57M in Q1 2021.
- 208 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2023.
Based on Shell Asset Management's 13F filing for Q2 2023, filed 28 Jul 2023.